Menggui Huang

Menggui Huang

Auto-generated profile, based on publicly available information

Menggui Huang

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2022 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
IVIoannis I. Verginadis
Ioannis I. Verginadis
HAHarris Avgousti
Harris Avgousti
JMJames Monslow
James Monslow
GSGiorgos Skoufos
Giorgos Skoufos
FCFrank Chinga
Frank Chinga
CKConstantinos Koumenis
Constantinos Koumenis
Bidirectional signalling between the tumour and stroma shapes tumour aggressiveness and metastasis. ATF4 is a major effector of the Integrated Stress Response, a homeostatic mechanism that couples cell growth and survival to bioenergetic demands. Using conditional knockout ATF4 mice, we show that global, or fibroblast-specific loss of host ATF4, results in deficient vascularization and a pronounced growth delay of syngeneic melanoma and pancreatic tumours. Single-cell transcriptomics of tumours grown in Atf4Δ/Δ mice uncovered a reduction in activation markers in perivascular cancer-associated fibroblasts (CAFs). Atf4Δ/Δ fibroblasts displayed significant defects in collagen biosynthesis and deposition and a reduced ability to support angiogenesis. Mechanistically, ATF4 regulates the expression of the Col1a1 gene and levels of glycine and proline, the major amino acids of collagen. Analyses of human melanoma and pancreatic tumours revealed a strong correlation between ATF4 and collagen levels. Our findings establish stromal ATF4 as a key driver of CAF functionality, malignant progression and metastasis.

26 February 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MHMenggui Huang
Menggui Huang
Duo ZhangDuo Zhang
Duo Zhang
JWJanet Wu
Janet Wu
KXKun Xing
Kun Xing
EYEujin Yeo
Eujin Yeo
YFYi Fan
Yi Fan
Therapeutic resistance remains a persistent challenge for patients with malignant tumors. Here, we reveal that endothelial cells (ECs) acquire transformation into mesenchymal stem cell (MSC)–like cells in glioblastoma (GBM), driving tumor resistance to cytotoxic treatment. Transcriptome analysis by RNA sequencing (RNA-seq) revealed that ECs undergo mesenchymal transformation and stemness-like activation in GBM microenvironment. Furthermore, we identified a c-Met–mediated axis that induces β-catenin phosphorylation at Ser675 and Wnt signaling activation, inducing multidrug resistance–associated protein-1(MRP-1) expression and leading to EC stemness-like activation and chemoresistance. Last, genetic ablation of β-catenin in ECs overcome GBM tumor resistance to temozolomide (TMZ) chemotherapy in vivo. Combination of Wnt inhibition and TMZ chemotherapy eliminated tumor-associated ECs, inhibited GBM growth, and increased mouse survival. These findings identified a cell plasticity–based, microenvironment-dependent mechanism that controls tumor chemoresistance, and suggest that targeting Wnt/β-catenin–mediated EC transformation and stemness activation may overcome therapeutic resistance in GBM.

13 April 2022 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
MHMenggui Huang
Menggui Huang
FYFan Yang
Fan Yang
Duo ZhangDuo Zhang
Duo Zhang
MLMaohuan Lin
Maohuan Lin
HDHao Duan
Hao Duan
YGYanqing Gong
Yanqing Gong